top of page
Latest News
12/08/2025
iPETcertum-by-Claritas-Developed-with-Cutting-Edge-Technology-for-Enhancement-Automated-Segmentation-and-Accurate-Quantification-in-PET-PET-CT-MRI-Scans-Receives-FDA-Clearance.html
LONDON and NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art signal processing, quantification and AI technologies for the nuclear medicine industry, is pleased to announce that iPETcertumâ„¢, a software device for enhancement, automated segmentation and quantification in PET (Positron Emission Tomography) scans has received FDA clearance.

bottom of page





